Yang et al. found that hnRNPA2/B1’s, a new COX-2 modulator, up-regulated expression predicts poor prognosis for NSCLC patients, indicating that hnRNPA2/B1 promotes tumors [46]. This evidence concerns the gene HNRNPA2B1 and non-small cell lung carcinoma.